Related references
Note: Only part of the references are listed.The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer
J. H. Park et al.
ANNALS OF ONCOLOGY (2014)
The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial
A. Huijbers et al.
ANNALS OF ONCOLOGY (2013)
Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)
T. J. A. Dekker et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer
Z. M. A. Mohammed et al.
BRITISH JOURNAL OF CANCER (2013)
Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer
Z. M. A. Mohammed et al.
BRITISH JOURNAL OF CANCER (2012)
The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer
Z. M. A. Mohammed et al.
BRITISH JOURNAL OF CANCER (2012)
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression
Paolo Cirri et al.
CANCER AND METASTASIS REVIEWS (2012)
The prognostic value of tumour-stroma ratio in triple-negative breast cancer
A. M. Moorman et al.
EJSO (2012)
Breast cancer outcomes by steroid hormone receptor status assessed visually and by computer image analysis
Zahra M. A. Mohammed et al.
HISTOPATHOLOGY (2012)
Tumor-Stroma Ratio Is an Independent Predictor for Survival in Esophageal Squamous Cell Carcinoma
Kai Wang et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Targeting stroma to treat cancers
Boris Engels et al.
SEMINARS IN CANCER BIOLOGY (2012)
Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients
Esther M. de Kruijf et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
Wolf Herman Fridman et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The mechanisms of cancer immunoescape and development of overcoming strategies
Tomonori Yaguchi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients
N. P. West et al.
BRITISH JOURNAL OF CANCER (2010)
The stromal part of adenocarcinomas of the oesophagus: Does it conceal targets for therapy?
Ewout F. W. Courrech Staal et al.
EUROPEAN JOURNAL OF CANCER (2010)
Estimates of cancer incidence and mortality in Europe in 2008
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2010)
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Francesco Colotta et al.
CARCINOGENESIS (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Microenvironmental regulation of cancer development
Min Hu et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Hua Yu et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Inflammation and prognosis in colorectal cancer
K Klintrup et al.
EUROPEAN JOURNAL OF CANCER (2005)
Tumour-stromal interactions in breast cancer: The role of stroma in tumourigenesis
JB Kim et al.
TUMOR BIOLOGY (2005)
Histological categorisation of fibrotic cancer stroma in advanced rectal cancer
H Ueno et al.
GUT (2004)
Prognostic factors in node-negative breast cancer - A review of studies with sample size more than 200 and follow-up more than 5 years
AN Mirza et al.
ANNALS OF SURGERY (2002)
Share Paper
